Skin cancer doesn't announce itself. It builds quietly, year after year, as UV exposure accumulates in your skin's cells — triggering DNA damage that eventually tips into malignancy. By the time most people take it seriously, they've already spent decades unprotected.

The good news — and there is significant good news — is that skin cancer is one of the most preventable cancers, and the tools available today extend far beyond sunscreen. A growing body of clinical evidence now validates a multi-layer approach to photoprotection that includes oral supplements, specifically nicotinamide and Polypodium leucotomos, as powerful daily defenders of skin health.

The Scale of the Problem

Skin Cancer by the Numbers

The statistics are stark — and they're getting worse, not better. Understanding the scale of skin cancer is the first step toward taking prevention seriously.

The Three Types You Need to Know

Not all skin cancers are equal in their danger, but all three major types are linked to UV exposure and share a common prevention story.

The trajectory is clear: skin cancer incidence is rising. Melanoma cases have increased by 4.3% year-over-year, and overall diagnoses continue to climb despite decades of public awareness campaigns. The problem isn't lack of awareness — it's that most people's protection strategies are incomplete.

Sunscreen alone isn't enough. Not because sunscreen doesn't work — it does — but because most people don't use it correctly, consistently, or comprehensively. A complete photoprotection strategy requires multiple layers. And the clinical science now gives us a powerful one that works from within.

The Clinical Evidence — Ingredient 01

Nicotinamide: Daily Protection That Works at the DNA Level

Nicotinamide — a form of vitamin B3 — is the most clinically validated oral ingredient for non-melanoma skin cancer prevention. Its mechanism is cellular: UV radiation triggers DNA strand breaks in skin cells, and nicotinamide enhances the body's own DNA repair pathways to correct that damage before it becomes permanent.

Beyond DNA repair, nicotinamide reduces UV-induced immunosuppression — the phenomenon by which sun exposure temporarily disables the skin's immune sentinels, creating a window of vulnerability for abnormal cell growth. By preserving immune function in UV-exposed skin, nicotinamide adds a second layer of protection that no topical sunscreen can replicate.

The key is dose and consistency. The clinical benefit requires 500 mg of nicotinamide daily — taken every day, not just on sunny ones. UV damage accumulates from all sources, including incidental daily exposure. This is why nicotinamide functions best as a daily supplement, not a situational one.

What makes these findings so significant is the scale and real-world design. The Vanderbilt study wasn't a controlled lab environment — it was 33,833 actual patients in a healthcare system, reflecting real-world use patterns. The results compound the 2015 RCT findings and give dermatologists a clear basis for recommending nicotinamide in high-risk patients.

Importantly, the benefit is cumulative. Nicotinamide works by enhancing your skin's ongoing repair capacity — the longer and more consistently it's taken, the greater the protective effect. This is not a supplement you take before a beach day. It's one you take every morning, year-round, as a fundamental layer of skin health maintenance.

The Clinical Evidence — Ingredient 02

Polypodium Leucotomos: Raising Your Skin's UV Threshold

Polypodium leucotomos extract (PLE) is derived from a tropical Central American fern that has been studied for its photoprotective properties for decades. Its mechanism is different from nicotinamide — and complementary to it. Where nicotinamide works at the DNA repair level, PLE works as a potent systemic antioxidant, neutralizing reactive oxygen species generated by UV exposure before they can trigger the inflammatory and cellular damage cascades that lead to cancer.

PLE's active compounds — caffeic acid and ferulic acid — also preserve Langerhans cells, the immune surveillance cells in the skin that UV depletes. This matters because Langerhans cells are part of the skin's first line of defense against malignant cell changes. When UV radiation wipes them out, it doesn't just cause a sunburn — it temporarily blinds the skin's cancer surveillance system.

The measurable result of PLE supplementation is a higher minimal erythema dose (MED) — the UV threshold before skin damage begins. Clinical trials consistently show that regular PLE users need more UV exposure before damage occurs, meaning their skin is intrinsically more resilient.

Building the Routine

Why You Need Every Layer — And What Each One Does

No single tool provides complete protection against skin cancer. UV radiation is persistent, cumulative, and reaches you in ways you don't expect — through car windows, on cloudy days, reflected off water and pavement. A complete strategy stacks multiple independent layers of defense, each working differently, none replacing the others.

Think of it like a building's fire protection system. You don't choose between smoke detectors, sprinklers, and fire exits — you use all three, because each catches what the others might miss.

The clinical evidence is unambiguous: people who use multiple layers of protection consistently outperform those who rely on any single strategy alone. Sunscreen wearers who also take oral photoprotective supplements have better outcomes than sunscreen-only users. And the oral layer works even when sunscreen is applied imperfectly — which, for most people, is most of the time.

Who Should Start Now

The Earlier You Start, the Greater the Benefit

The Vanderbilt study's most important finding wasn't the 54% — it was the implication that earlier initiation yields better outcomes. Patients who began nicotinamide after a first skin cancer diagnosis (not after multiple) showed the greatest benefit. This strongly suggests that waiting for a cancer diagnosis to start is waiting too long.

The dermatologists at Soleil Derm recommend considering daily nicotinamide supplementation for anyone in the following categories:

Nicotinamide's safety profile is well-established — it's a form of vitamin B3, not a pharmaceutical drug, and has no significant interactions with common supplements or medications. As always, we recommend discussing with your dermatologist or physician before starting any new supplement regimen.

The Soleil Derm Solution

How Ombré Was Built Around This Science

At Soleil Derm, every formulation decision begins with the clinical literature. When our dermatologists developed Ombré, the standard was simple: match the doses that the studies actually used. No proprietary blends that obscure how much of each ingredient you're getting. No cosmetic doses dressed up in clinical language.

Ombré delivers 500 mg of nicotinamide per capsule — the exact dose validated across multiple large-scale studies — alongside clinically dosed Polypodium leucotomos extract, curcumin for anti-inflammatory support, omega-3 fatty acids to increase UV resistance, and vitamin D. It is the complete inside-out photoprotection stack in a single daily capsule.

Early Detection Saves Lives

Prevention Is Only Half the Picture

Early-stage melanoma has a near-100% five-year survival rate. Advanced melanoma drops to 35%. That gap is not a treatment story — it's a detection story. The most powerful thing you can do after building a daily protection routine is to see a dermatologist for an annual full-body skin exam.

In between annual visits, the ABCDE rule is your guide for self-examination:

If you notice any of these signs, don't wait for your annual exam. Schedule a dermatology appointment promptly. When in doubt, get it checked.

Medical Disclaimer: This content is for educational purposes and does not constitute medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your dermatologist or physician before beginning any new supplement regimen. Sun protection supplements complement, but do not replace, topical sunscreen and other photoprotective behaviors.

Sources: American Academy of Dermatology — Skin Cancer Awareness Month 2025 · Chen et al., NEJM 2015 — PMC Full Text · Wheless et al., JAMA Dermatology September 2025 — Vanderbilt Health News · Berman et al., JCAD 2015 · PMC systematic review of 79 PLE publications, 2022 · American Cancer Society Cancer Facts & Figures 2025 · Melanoma Research Alliance 2025 · Schweiger Dermatology Group 2026.